Richard Kelly was interviewed by Asia IP Law regarding the legal, economic and political challenges facing the global pharmaceutical industry in 2016. Mr. Kelly's contributions to the piece was recently published in the March issue of the Asia IP magazine.
Asia IP Law
Oblon has been recognized as "PTAB Firm of the Year" by Managing Intellectual Property magazine for its second annual PTAB litigation ranking. This award recognizes Oblon's outstanding work and reputation in representing petitioners and patent owners before the Patent Trial and Appeal Board at the United States Patent and Trademark Office. During Thursday night's award ceremony, the firm was also dubbed "Northeast Patent Prosecution Firm of the Year."
Managing Intellectual Property
Richard Kelly was recently interviewed by Asia IP Law regarding the legal, economic and political challenges facing the global pharmaceutical industry in 2016. Mr. Kelly's contributions to the piece will be published in the March issue of the magazine.
Asia IP Law
The firm has been shortlisted to receive the following MIP US awards. Patent Prosecution- National PTAB- National Specialty IP Firm- National Patent Prosecution- Regional (Northeast)
Managing IP Magazine
The Federal Circuit on Monday affirmed a Patent Trial and Appeal Board decision that the asserted claims of a prenatal DNA test patent owned by Stanford University are invalid because they are obvious and anticipated.
Oblon was recently highlighted in an IP Law360 article as a top firm for handing AIA reviews at the PTAB. Oblon ranked fourth in terms of overall number of AIA review cases in 2015.
Oblon Announces Election of One New Partner, Five New Senior Attorneys and Two New Senior Associates
Alexandria, VA – Oblon, McClelland, Maier & Neustadt, LLP is pleased to announce the election of one new partner- Sameer Gokhale- effective January 1, 2016.
In survey results recently published by IP Law360, Oblon was ranked #35 in the list of the "Top 100 IP Firms" by number of partners
Oblon was mentioned in a recent Law360 article regarding a recent Federal Circuit decision to vacate a PTAB decision in an inter partes review which upheld all of the claims of Verinata Health Inc.'s patent on a method of detecting fetal abnormalities.
Oblon was named one of the "Best Law Firms" in the United States in 2019 by U.S. News and World Report and Best Lawyers.
U.S. News and World Report and Best Lawyers.